The social value of a QALY: raising the bar or barring the raise?-Reference-Cited by-同舟云学术

The social value of a QALY: raising the bar or barring the raise?

Published:2011-01-11 Issue:1 Volume:11 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Donaldson Cam,Baker Rachel,Mason Helen,Jones-Lee Michael,Lancsar Emily,Wildman John,Bateman Ian,Loomes Graham,Robinson Angela,Sugden Robert,Prades Jose Luis Pinto,Ryan Mandy,Shackley Phil,Smith Richard

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/article/10.1186/1472-6963-11-8/fulltext.html

Reference39 articles.

1. Phelps CE, Mushlin AI: On the (near) equivalence of cost-effectiveness and cost-benefit analyses. International Journal of Technology Assessment in Health Care. 1991, 7: 12-21. 10.1017/S0266462300004803.

2. Hirth RA, Chernew ME, Miller E, Fendrick M, Weissert WG: Willingness to pay for a quality-adjusted life year: in search of a standard. Medical Decision Making. 2000, 20: 332-42. 10.1177/0272989X0002000310.

3. Gyrd-Hansen D: Willingness to pay for a QALY. Health Economics. 2003, 12: 1049-60. 10.1002/hec.799.

4. Byrne MM, O'Malley K, Suarez-Almazor ME: Willingness to pay per quality adjusted life year in a study of knee osteoarthritis. Medical Decision Making. 2005, 25: 655-666. 10.1177/0272989X05282638.

5. King JT, Tsevat J, Lave J, Roberts MS: Willingness to pay for a quality adjusted life year: implications for societal resource allocation. Medical Decision Making. 2005, 25: 667-677. 10.1177/0272989X05282640.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measuring the overall performance of mental healthcare providers;Social Science & Medicine;2024-03

2. A systematic review on the direct approach to elicit the demand-side cost-effectiveness threshold: Implications for low- and middle-income countries;PLOS ONE;2024-02-08

3. An enhanced multilevel secure data dissemination approximate solution for future networks;PLOS ONE;2024-02-08

4. Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method;Cost Effectiveness and Resource Allocation;2023-11-02

5. Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers;PharmacoEconomics;2023-06-09